European Union - English - EMA (European Medicines Agency)

mallinckrodt deutschland gmbh - gadoversetamide - magnetic resonance imaging - contrast media - this medicinal product is for diagnostic use only.optimark is indicated for use with magnetic resonance imaging (mri) of the central nervous system (cns) and liver. it provides contrast enhancement and facilitates visualisation and helps with the characterisation of focal lesions and abnormal structures in the cns and liver in patients with known or highly suspected pathology.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - adenosine, quantity: 6 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - therapeutic indications: adenosine viatris is indicated for the rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (wolff-parkinson-white syndrome). diagnostic indications: adenosine viatris is indicated as an aid to diagnosis of broad or narrow qrs complex supraventricular tachycardias. although adenosine viatris is not effective in converting atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of av conduction helps diagnosis of atrial activity. in this respect adenosine should be used as an adjunct to, but not a replacement for, clinical and ecg observations. it should be used only when, despite all diagnostic attempts, doubt still persists. adenosine viatris can also be used for improved diagnostic sensitivity of intracavity electrophysiological investigations.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - dextromethorphan hydrobromide monohydrate, quantity: 10.5 mg - pastille - excipient ingredients: menthol; acacia; saccharin sodium; white beeswax; betadex; quinoline yellow; sodium cyclamate; light liquid paraffin; maltitol solution; citric acid; flavour - bisolvon dry pastilles are used for the symptomatic treatment of dry, irritant, unproductive coughs and helps soothe the throat.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - adenosine, quantity: 3 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - therapeutic indications: rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory by-pass tracts (wolff-parkinson-white syndrome). diagnostic indications: aid to diagnosis of broad or narrow complex supraventricular tachycardias. although adenocor is not effective in converting atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of av conduction helps diagnosis of atrial activity. in this respect adenosine should be used as an adjunct to, but not a replacement for, clinical and ecg observations. it should be only used when, despite all diagnostic attempts, doubt still persists. improved diagnostic sensitivity of intracavity electrophysiological investigations

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium selenate decahydrate, quantity: 467 microgram (equivalent: selenium, qty 100 microgram) - injection, intravenous infusion - excipient ingredients: water for injections - indications as at 01 march 1998 : this formulation is indicated for use as a supplement to iv solutions given for tpn. administation of the solution in tpn solutions helps to maintain plasma levels of copper, manganese, and selenium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. cancer: prophylaxis of malignant neoplasms via selenium supplementation.

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium selenate decahydrate, quantity: 111 microgram (equivalent: selenium, qty 24 microgram) - injection, intravenous infusion - excipient ingredients: water for injections - indications as at 01 march 1998 : this formulation is indicated for use as a supplement to iv solutions given for tpn. administation of the solution in tpn solutions helps to maintain plasma levels of copper, manganese, and selenium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. cancer: prophylaxis of malignant neoplasms via selenium supplementation.

United States - English - NLM (National Library of Medicine)

humanenos llc - nitric oxide (unii: 31c4ky9esh) (nitric oxide - unii:31c4ky9esh) - 500mg x 60 / 1.058oz ibsibd n:o 180 start ibsibd n:o 180 start

United States - English - NLM (National Library of Medicine)

humanenos llc - nitric oxide (unii: 31c4ky9esh) (nitric oxide - unii:31c4ky9esh) - 350 mg x 60 / 0.74 oz bio n:o pharm v bio n:o pharm v

United States - English - NLM (National Library of Medicine)

humanenos llc - nitric oxide (unii: 31c4ky9esh) (nitric oxide - unii:31c4ky9esh) - bio n:o more menopause bio n:o more menopause

United States - English - NLM (National Library of Medicine)

humanenos llc - nitric oxide (unii: 31c4ky9esh) (nitric oxide - unii:31c4ky9esh) - bio n:o more joint pain bio n:o more joint pain